Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - hmer.
SCARPONI, D; Iskauskas, A; CLARK, RA; Vernon, I; McKinley, TJ; Goldstein, M; Mukandavire, C; Deol, A; Weerasuriya, C; Bakker, R; WHITE, RG; MCCREESH, N;
2023
Epidemics, (2023).43, 10.1016/j.epidem.2023.100678.
New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01 E and BCG-revaccination.
CLARK, RA; Weerasuriya, CK; Portnoy, A; Mukandavire, C; Quaife, M; Bakker, R; SCARPONI, D; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;
2023
medRxiv (2023). 10.1101/2023.02.24.23286406.
Cost-effectiveness of tuberculosis infection prevention and control interventions in South African clinics: a model-based economic evaluation informed by complexity science methods.
BOZZANI, FM; MCCREESH, N; Diaconu, K; GOVENDER, I; WHITE, RG; Kielmann, K; GRANT, AD; VASSALL, A;
2023
BMJ Global Health, (2023).8 2 10.1136/bmjgh-2022-010306.
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
Portnoy, A; CLARK, RA; Quaife, M; WEERASURIYA, CK; Mukandavire, C; Bakker, R; Deol, AK; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, RG; Menzies, NA;
2023
PLOS Medicine, (2023).20 1 10.1371/journal.pmed.1004155.
Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: A modelling study.
Mwenda, V; Jalang'o, R; Miano, C; Bor, J-P; Nyangasi, M; Mecca, L; Were, V; Kariithi, E; Pecenka, C; Schuind, A; ABBAS, K; CLARK, A;
2023
Vaccine, (2023).41 29 10.1016/j.vaccine.2023.05.019.
Modeling the potential health impact of prospective Strep A vaccines.
Giannini, F; Cannon, JW; Cadarette, D; Bloom, DE; Moore, HC; Carapetis, J; ABBAS, K;
2023
NPJ vaccines, (2023).8 1 10.1038/s41541-023-00668-0.
Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study.
KIM, C; Holm, M; Frost, I; Hasso-Agopsowicz, M; ABBAS, K;
2023
BMJ global health, (2023).8 7 10.1136/bmjgh-2022-011341.
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
AUZENBERGS, M; FU, H; ABBAS, K; PROCTER, SR; Cutts, FT; JIT, M;
2023
The Lancet. Global health, (2023).11 8 10.1016/S2214-109X(23)00220-6.
Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis.
PREM, K; Choi, YH; Bénard, É; Burger, EA; Hadley, L; Laprise, J-F; Regan, MC; Drolet, M; Sy, S; ABBAS, K; Portnoy, A; Kim, JJ; Brisson, M; JIT, M;
2023
BMC medicine, (2023).21 1 10.1186/s12916-023-02988-3.
The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation efforts.
Lee, J-S; Mogasale, V; Kim, S; Cannon, J; Giannini, F; ABBAS, K; Excler, J-L; Kim, JH;
2023
npj vaccines, (2023).8 1 10.1038/s41541-023-00718-7.